N4 Pharma Plc (FRA:0GO)

N4 Pharma Statistics

Total Valuation

N4 Pharma has a market cap or net worth of EUR 5.44 million. The enterprise value is 3.48 million.

Market Cap	5.44M
Enterprise Value	3.48M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	832.28M
Shares Outstanding	n/a
Shares Change (YoY)	+80.86%
Shares Change (QoQ)	+45.46%
Owned by Insiders (%)	19.50%
Owned by Institutions (%)	56.72%
Float	517.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	660.42
PB Ratio	2.64
P/TBV Ratio	2.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.71
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.55

Current Ratio	23.55
Quick Ratio	23.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.18% and return on invested capital (ROIC) is -49.29%.

Return on Equity (ROE)	-74.18%
Return on Assets (ROA)	-47.21%
Return on Invested Capital (ROIC)	-49.29%
Return on Capital Employed (ROCE)	-67.97%
Revenue Per Employee	2,061
Profits Per Employee	-321,487
Employee Count	4
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-81,350
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	48.15
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, N4 Pharma had revenue of EUR 8,243 and -1.29 million in losses. Loss per share was -0.00.

Revenue	8,243
Gross Profit	8,243
Operating Income	-1.40M
Pretax Income	-1.40M
Net Income	-1.29M
EBITDA	n/a
EBIT	-1.40M
Loss Per Share	-0.00

Balance Sheet

The company has 2.02 million in cash and n/a in debt, giving a net cash position of 2.02 million.

Cash & Cash Equivalents	2.02M
Total Debt	n/a
Net Cash	2.02M
Net Cash Per Share	n/a
Equity (Book Value)	2.06M
Book Value Per Share	0.00
Working Capital	2.06M

Cash Flow

Operating Cash Flow	-1.20M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-17,001.07%
Pretax Margin	-16,977.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

N4 Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-80.86%
Shareholder Yield	-80.86%
Earnings Yield	-23.62%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

N4 Pharma has an Altman Z-Score of 9.87 and a Piotroski F-Score of 2.

Altman Z-Score	9.87
Piotroski F-Score	2